Hopp til innhold
Close

Get alerts of updates about «Does long-term use of medication affect cognition and health later in life?»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Does long-term use of medication affect cognition and health later in life?

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Project

Does long-term use of medication affect cognition and health later in life? - project description

Published Updated

Do certain types of medication counteract or contribute to dementia?


Summary

Life expectancy has steadily increased over the past two centuries, while there seems to be less improvement in cognitive decline. The consequence is a considerable rise in the number of elderly with various degrees of dementia. The question is whether certain types of medication can either counteract or contribute to this aspect of aging. One of us has recently shown that even a short-term treatment with the commonly used asthma medicine montelukast can ameliorate a similar decline in rats. Based on analyses of the Norwegian Prescription Database, we found evidence suggesting that montelukast also helps humans. We wish to combine the Tromsø data with the Prescription Database in order to test whether individuals using montelukast, as well as other medications, score worse or better on relevant tests later in life. The Tromsø study offers a unique opportunity to investigate long-term effects of pharmaca.

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Bjørn Grinde, Norwegian Institute of Public Health

Project participants

Bjørn Heine Strand, Norwegian Institute of Public Health
Bjørn Grinde, Avdeling for kroniske sykdommer og aldring, Norwegian Institute of Public Health
Henrik Schirmer, UiT The Arctic University of Norway
Ludwig Aigner, Paracelsus Private Medical University
Anne-Elise Eggen, UiT The Arctic University of Norway

Start

12.01.2016

End

31.12.2021

Status

Active

Approvals

Regional committees for medical and health research ethics

Project owner/ Project manager

Norwegian Institute of Public Health

Project manager

Bjørn Grinde

Participant at FHI

Bjørn Heine Strand